Possible applications of gliptins (dipeptidyl peptidase-4 inhibitors) in patients with type 2 diabetes mellitus on the various modes of insulin therapy
The evidence for DPP-4 inhibitors effectiveness at the late stages of type 2 diabetes mellitus (T2DM) are still growing. This is particularly important for those patients who receive insulin without adequately glycemic control. This publication provides the overview of studies which demonstrate high...
Enregistré dans:
Auteurs principaux: | , |
---|---|
Format: | article |
Langue: | EN RU |
Publié: |
Endocrinology Research Centre
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d475d6cca7794363a7a0ff5051ec970b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|